P.E. de Jong

601 total citations
15 papers, 415 citations indexed

About

P.E. de Jong is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P.E. de Jong has authored 15 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P.E. de Jong's work include Renal Diseases and Glomerulopathies (3 papers), Dialysis and Renal Disease Management (3 papers) and Renin-Angiotensin System Studies (3 papers). P.E. de Jong is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Dialysis and Renal Disease Management (3 papers) and Renin-Angiotensin System Studies (3 papers). P.E. de Jong collaborates with scholars based in Netherlands, Pakistan and Curacao. P.E. de Jong's co-authors include Dick de Zeeuw, Coen A. Stegeman, A. J. M. Donker, G.K. van der Hem, W.J. Sluiter, R. M. Huisman, Harry van Goor, Frits Hein Wapstra, Gerjan Navis and A J Apperloo and has published in prestigious journals such as Kidney International, Nephrology Dialysis Transplantation and Clinical Science.

In The Last Decade

P.E. de Jong

15 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.E. de Jong Netherlands	12	189	172	103	103	51	15	415
F Gómez-Campderá Spain	12	270 1.4×	157 0.9×	78 0.8×	68 0.7×	110 2.2×	19	546
A J Apperloo Netherlands	6	194 1.0×	235 1.4×	58 0.6×	144 1.4×	28 0.5×	7	419
Pierre F. Faubert United States	10	212 1.1×	187 1.1×	112 1.1×	71 0.7×	50 1.0×	17	443
Amparo Miralles Spain	11	179 0.9×	331 1.9×	89 0.9×	75 0.7×	63 1.2×	26	463
Makoto Ishizaki Japan	7	190 1.0×	193 1.1×	57 0.6×	146 1.4×	46 0.9×	31	457
Pe Dejong Pakistan	9	148 0.8×	152 0.9×	38 0.4×	103 1.0×	24 0.5×	19	330
Mai Ots Estonia	13	269 1.4×	228 1.3×	54 0.5×	91 0.9×	82 1.6×	19	579
C. Wanner Germany	11	188 1.0×	100 0.6×	59 0.6×	89 0.9×	70 1.4×	24	376
Gerjan Navis Netherlands	11	133 0.7×	160 0.9×	107 1.0×	100 1.0×	101 2.0×	15	415
Karin Tyralla Germany	8	323 1.7×	236 1.4×	78 0.8×	57 0.6×	58 1.1×	8	552

Countries citing papers authored by P.E. de Jong

Since Specialization

Citations

This map shows the geographic impact of P.E. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.E. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.E. de Jong more than expected).

Fields of papers citing papers by P.E. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.E. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.E. de Jong. The network helps show where P.E. de Jong may publish in the future.

Co-authorship network of co-authors of P.E. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of P.E. de Jong. A scholar is included among the top collaborators of P.E. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.E. de Jong. P.E. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Stegeman, Coen A., et al.. (2004). Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. Nephrology Dialysis Transplantation. 19(5). 1212–1223. 30 indexed citations

Tobe, Takashi, et al.. (2004). Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrology Dialysis Transplantation. 19(5). 1168–1173. 18 indexed citations

Zeeuw, Dick de, et al.. (2001). Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease. Seminars in Nephrology. 21(6). 580–592. 12 indexed citations

Wapstra, Frits Hein, Harry van Goor, P.E. de Jong, Gerjan Navis, & Dick de Zeeuw. (1999). Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis. Journal of Pharmacological and Toxicological Methods. 41(2-3). 69–73. 30 indexed citations

Apperloo, A J, et al.. (1997). Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?. PubMed. 63. S58–62. 37 indexed citations

Zeeuw, Dick de, et al.. (1997). A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney International. 51(3). 793–797. 152 indexed citations

Navis, Gerjan, Hanneke Buter, P.E. de Jong, Robin P. F. Dullaart, & Dick de Zeeuw. (1997). Effect of Antiproteinuric Treatment on the Lipid Profile in Nondiabetic Renal Disease. Contributions to nephrology. 120. 88–96. 4 indexed citations

Zeeuw, Dick de, R. T. Gansevoort, & P.E. de Jong. (1995). Losartan in patients with renal insufficiency.. PubMed. 11 Suppl F. 41F–44F. 6 indexed citations

Vriesendorp, R., et al.. (1992). Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.. PubMed. 7 Suppl 1. 91–6. 22 indexed citations

10.

Jong, P.E. de, et al.. (1989). Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis.. PubMed. 30(5). 605–14. 22 indexed citations

11.

Kraan, J, et al.. (1988). The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease. European Journal of Clinical Pharmacology. 35(4). 357–362. 14 indexed citations

12.

Jong, P.E. de, et al.. (1986). Restenosis Prevalence and Long-Term Effects on Renal Function after Percutaneous Transluminal Renal Angioplasty. The Nephron journals/Nephron journals. 44(1). 64–67. 27 indexed citations

13.

Meijer, S., N. H. Mulder, D.Th. Sleijfer, et al.. (1983). Influence of Combination Chemotherapy with <i>cis</i>-Diamminedichloroplatinum on Renal Function: Long-Term Effects. Oncology. 40(3). 170–173. 13 indexed citations

14.

Jong, P.E. de, et al.. (1982). The Influence of Indomethacin on Renal Concentrating and Diluting Capacity in Sickle Cell Nephropathy. Clinical Science. 63(1). 53–58. 18 indexed citations

15.

Jong, P.E. de, et al.. (1980). Effect of Indomethacin in Two Siblings with a Renin-Dependent Hypertension, Hyperaldosteronism and Hypokalemia. The Nephron journals/Nephron journals. 25(1). 47–52. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact